Profilo
Simon Mangcwatywa is currently the Chief Executive Officer at Sizwe Medical Fund since 2018.
Prior to this, he worked as the Medical Director at Adcock Ingram Holdings Ltd., Head-Scientific Operations at Novartis SA, and Head-Medical Affairs & Business Development at Litha Pharma (Pty) Ltd.
Posizioni attive di Simon Mangcwatywa
| Società | Posizione | Inizio |
|---|---|---|
Sizwe Medical Fund
Sizwe Medical Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Amministratore Delegato | 01/01/2018 |
Precedenti posizioni note di Simon Mangcwatywa
| Società | Posizione | Fine |
|---|---|---|
Litha Pharma (Pty) Ltd.
Litha Pharma (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets, and distributes pharmaceutical and generic products as well as medical devices | Corporate Officer/Principal | - |
Novartis SA
Novartis SA Pharmaceuticals: MajorHealth Technology Manufactures and markets health care, nutritional and agricultural products | Corporate Officer/Principal | - |
| ADCOCK INGRAM HOLDINGS LIMITED | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Novartis SA
Novartis SA Pharmaceuticals: MajorHealth Technology Manufactures and markets health care, nutritional and agricultural products | Health Technology |
Adcock Ingram Holdings Ltd.
Adcock Ingram Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures, markets and distributes non-price regulated health, personal and homecare products | Health Technology |
Litha Pharma (Pty) Ltd.
Litha Pharma (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets, and distributes pharmaceutical and generic products as well as medical devices | Health Technology |
Sizwe Medical Fund
Sizwe Medical Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
















